Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigation.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Jun 2016

Pelletier Sylvie, Wong Nora, El Haffaf Zaki, Foulkes William D, Chiquette Jocelyne, Hamet Pavel, Simard Jacques, Dorval Michel

Abstract excerpt

PURPOSE: Most women from BRCA1/2 mutation-positive families who did not inherit the familial mutation have breast and ovarian cancer risks similar to those of women of the same age in the general population. However, recent studies suggest that some of these noncarriers may exhibit screening practices that may be considered as excessive compared to general population screening guidelines. Reasons for such...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Canada

Share to Early Detection of Cancer

Share to Follow-Up Studies

Share to Heterozygote

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 26540155
DOI: 10.1038/gim.2015.135

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigation.PMID 26540155Read ↗

Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1/BRCA2 mutations.Semantic proximity Read ↗

The effect of BRCA gene testing on family relationships: A thematic analysis of qualitative interviews.Semantic proximity Read ↗

BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.Semantic proximity Read ↗

What Do Breast Cancer Previvors Tell Us About Their Stories? To Know or Not to Know?Semantic proximity Read ↗

Moving In and Out of the What-Ifs: The Experiences of Unaffected Women Living in Families Where a Breast Cancer 1 or 2 Genetic Mutation Was Not Found.Semantic proximity Read ↗

Family history and women with ovarian cancer: is it asked and does it matter?: An observational study.Semantic proximity Read ↗

Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.Semantic proximity Read ↗

Experiences and decisions that motivate women at increased risk of breast cancer to participate in an experimental screening program.Semantic proximity Read ↗

BRCA genetic testing of individuals from families with low prevalence of cancer: experiences of carriers and implications for population screening.Semantic proximity Read ↗

"For all my family's sake, I should go and find out": an Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancer.Semantic proximity Read ↗

Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up.Semantic proximity Read ↗

Living with genetic test results for hereditary breast and ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.